Revolution Medicines, Inc. (RVMD)
211.58
+2.12
(+1.01%)
USD |
NASDAQ |
Aug 24, 16:00
211.40
-0.18
(-0.09%)
After-Hours: 19:19
Revolution Medicines Max Drawdown (5Y) : 73.29% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 73.29% |
| June 30, 2026 | 73.29% |
| May 31, 2026 | 73.29% |
| April 30, 2026 | 73.29% |
| March 31, 2026 | 73.29% |
| February 28, 2026 | 73.29% |
| January 31, 2026 | 73.29% |
| December 31, 2025 | 73.29% |
| November 30, 2025 | 73.29% |
| October 31, 2025 | 73.29% |
| September 30, 2025 | 73.29% |
| August 31, 2025 | 73.29% |
| July 31, 2025 | 73.29% |
| June 30, 2025 | 73.29% |
| May 31, 2025 | 73.29% |
| April 30, 2025 | 73.29% |
| March 31, 2025 | 73.29% |
| February 28, 2025 | 73.29% |
| January 31, 2025 | 73.29% |
| December 31, 2024 | 73.29% |
| November 30, 2024 | 73.29% |
| October 31, 2024 | 73.29% |
| September 30, 2024 | 73.29% |
| August 31, 2024 | 73.29% |
| July 31, 2024 | 73.29% |
| Date | Value |
|---|---|
| June 30, 2024 | 73.29% |
| May 31, 2024 | 73.29% |
| April 30, 2024 | 73.29% |
| March 31, 2024 | 73.29% |
| February 29, 2024 | 73.29% |
| January 31, 2024 | 73.29% |
| December 31, 2023 | 73.29% |
| November 30, 2023 | 73.29% |
| October 31, 2023 | 73.29% |
| September 30, 2023 | 73.29% |
| August 31, 2023 | 73.29% |
| July 31, 2023 | 73.29% |
| June 30, 2023 | 73.29% |
| May 31, 2023 | 73.29% |
| April 30, 2023 | 73.29% |
| March 31, 2023 | 73.29% |
| February 28, 2023 | 73.29% |
| January 31, 2023 | 73.29% |
| December 31, 2022 | 73.29% |
| November 30, 2022 | 73.29% |
| October 31, 2022 | 73.29% |
| September 30, 2022 | 73.29% |
| August 31, 2022 | 73.29% |
| July 31, 2022 | 73.29% |
| June 30, 2022 | 73.29% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Tango Therapeutics, Inc. | 93.64% |
| Erasca, Inc. | 95.64% |
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
| Intellia Therapeutics, Inc. | 96.45% |
| Beam Therapeutics, Inc. | 89.12% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 29.17 |
| Beta (5Y) | 1.390 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 58.46% |
| Historical Sharpe Ratio (5Y) | 0.7178 |
| Historical Sortino (5Y) | 1.413 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.23% |